Real-Time AI Monitoring & Early Detection of Immune-Related Adverse Events
Join Dr. Mullin of the Roswell Park Comprehensive Cancer Center and Dr. Bao of the UPMC Hillman Cancer Center as they talk about artificial intelligence’s (AI’s) role in real-time monitoring of patients who are receiving immunotherapy for immune-related adverse events (irAE).
If you attend, you’ll learn about:
- the current application of AI in irAE monitoring and detection.
- future applications of these technologies across the field.
This webinar is the first of the 2024 SITC-NCI Computational Immuno-oncology Webinar Series, which focuses on the application of AI in immuno-oncology. It consists of nine free webinars to help individual research labs overcome computational challenges while analyzing and integrating different assay data throughout the immuno-oncology spectrum using AI. The annual series aims to educate early-career scientists, increase participants’ awareness of and engagement in NCI-supported Cancer Moonshot℠ Immunotherapy Networks, and fulfill the Blue Ribbon Panel’s goal of accelerating progress in cancer research.
Dr. Mullin serves as an assistant professor of oncology at Roswell Park Comprehensive Cancer Center.
Dr. Bao is the co-director of bioinformatics at UPMC Hillman Cancer Center.
Upcoming Events
- Envisioning a Future Toward More Equitable Trials: Artificial Intelligence and Its Implications in Health EquitySeptember 09, 2024 - September 10, 2024Impact of the Molecular Characterization Initiative on Pediatric CNS TumorsSeptember 10, 2024AI and Global OncologySeptember 24, 2024NCI’s Clinical and Translational Data Commons: Your Resource for Cancer DiscoverySeptember 25, 2024NCI Office of Data Sharing’s Annual Data Sharing Symposium: Driving Cancer Advances Through Impactful ResearchOctober 16, 2024The Cancer Research Data Commons 2024 Fall Symposium: Ten Years of Empowering Cancer ResearchersOctober 16, 2024 - October 17, 2024